Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

EMD-221829, a new PDE5 inhibitor: correlation of pharmacokinetics and pharmacodynamics

Nov. 2, 2000

Nastech's intranasal apomorphine enters phase II for MED

Oct. 31, 2000

Antifibrotic agents patented by Sumitomo

Oct. 27, 2000

ASA 2000: Ono-5046 protects against I/R-induced renal injury via effect on leukocyte activation

Oct. 25, 2000

KMD-3213: binding kinetics and pharmacological activity correlated in vivo

Oct. 25, 2000

Vivus withdraws Alibra NDA

Oct. 23, 2000

New series of PDE5 inhibitors and their use described by Sanofi-Synthelabo

Oct. 19, 2000

Abbott researchers design novel water-soluble K+ channel openers

Oct. 17, 2000

Novel 5-HT reuptake inhibitors specifically claimed for use in premature ejaculation

Oct. 16, 2000

U.K. authorities clear new ED treatment for launch

Oct. 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...